يحاول ذهب - حر

Iberia Pharma set to open manufacturing unit in India with investment of Rs 70 Cr

September 2025

|

Bio Spectrum

Gurugram-based Iberia Pharmaceuticals has announced its new hi-tech manufacturing and research facility spread across 60,000 sq. ft. in Jhajjar, Haryana.

Iberia Pharma set to open manufacturing unit in India with investment of Rs 70 Cr

The next-generation unit is expected to be operational by mid of 2026. The facility is designed to serve customers with science-baked, derma-driven, wellness products. The company has made a massive investment of Rs 70 crore and is proud to be a part of the government backed 'Make-inIndia' movement. This unit is equipped with best

المزيد من القصص من Bio Spectrum

Bio Spectrum

Bio Spectrum

Are BioStartUps in a Funding/Innovation Rut?

At the BioStartUps Founders & Investors Forum 2025, held on August 1, 2025 at the CIDCO Exhibition Centre in Vashi, Navi Mumbai, biotech industry stalwarts deliberated on the country's innovation and startup ecosystem.

time to read

10 mins

September 2025

Bio Spectrum

Bio Spectrum

HealthQuad appoints Namit Chugh as Director

Quadria Group, Asia's leading healthcare-focused private equity platform, has announced the appointment of Namit Chugh as Director at HealthQuad, India's leading healthcare-focused growth venture capital platform.

time to read

1 min

September 2025

Bio Spectrum

Bio Spectrum

Why Is Endoscopy Crucial for Gl Cancer Diagnosis?

The increased demand for gastrointestinal (GI) diagnostics in India, driven by rising disease rates and awareness of early intervention, is not evenly distributed. While major urban hospitals have expanded their endoscopic capabilities, many semi-urban and rural areas face limited access. Addressing this disparity is crucial for extending the benefits of early disease detection across the country.

time to read

4 mins

September 2025

Bio Spectrum

New England Biolabs launches NEBNext low-bias small RNA library prep kit

US-based New England Biolabs (NEB) has announced the launch of the NEBNext Low-bias Small RNA Library Prep Kit, designed to minimise biased representation of small RNA species in sequencing data.

time to read

1 min

September 2025

Bio Spectrum

Bio Spectrum

Qiagen expands NGS portfolio with launch of QIAseq XHYB long read panels

Qiagen has announced the launch of its new QIAseq xHYB Long Read Panels, a suite of target enrichment solutions designed to unlock long-read sequencing of genomically complex regions.

time to read

1 min

September 2025

Bio Spectrum

Dr. Moopen's Legacy Scholarship & Fellowships to aid 25 students from across India

In a path breaking initiative to make medical education accessible to meritorious students and students from economically challenged backgrounds, Padma Shri Dr Azad Moopen, Founder & Chairman of Aster DM Healthcare and a globally recognised philanthropist, has announced an annual scholarship programme Dr. Moopen's Legacy Scholarship & Fellowships Programme aimed at supporting meritorious students seeking admissions in Dr. Moopen's Medical College, Dr Moopen's Nursing College and Dr Moopen's College of Pharmacy in Wayanad, Kerala.

time to read

1 min

September 2025

Bio Spectrum

Bio Spectrum

Iberia Pharma set to open manufacturing unit in India with investment of Rs 70 Cr

Gurugram-based Iberia Pharmaceuticals has announced its new hi-tech manufacturing and research facility spread across 60,000 sq. ft. in Jhajjar, Haryana.

time to read

1 min

September 2025

Bio Spectrum

Bio Spectrum

"Shortage of professionals with expertise in both AI and life sciences complicates adoption"

With its ability to both generate insights and act on them autonomously, agentic AI is poised to revolutionise the process of developing new therapies and bringing them to the market.

time to read

5 mins

September 2025

Bio Spectrum

Bio Spectrum

Al/loT-Driven Real-time Cardiac Event Prediction & Treatment

It is anticipated that between 2025 and 2050, a significant 50.2 per cent increase in cardiovascular mortality rates will result in 35.6 million cardiovascular deaths by 2050, of which ischemic heart disease or coronary heart disease will remain the leading cause, accounting for 56.2 per cent of fatalities in 2050.

time to read

2 mins

September 2025

Bio Spectrum

SCHOTT announces launch of syringe and cartridge glass tubing in India

SCHOTT, a global pioneer in specialty glass, has announced the addition of syringe and cartridge glass tubing to its existing state-ofthe-art manufacturing capabilities in Jambusar, Gujarat.

time to read

1 min

September 2025

Listen

Translate

Share

-
+

Change font size